Biomimetic Copper Nanoparticles Coated with ACE2‐Overexpressing Membranes for Selective SARS‐CoV‐2 Neutralization and Disinfection
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202505424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Pooja Aich und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal and Applied Chemistry, Kaohsiung Medical University, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Copper, Angiotensin-Converting Enzyme 2, Metal Nanoparticles, Biomimetic Materials. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Kaohsiung Medical University, National Research Foundation of Korea, Ministry of Education.
Abstract (Originalsprache)
The SARS‐CoV‐2 spike protein facilitates viral entry into host cells by binding to the human angiotensin‐converting enzyme 2 (ACE2) receptor. To exploit this mechanism for therapeutic intervention, a liposome fusion‐induced membrane exchange (LIME) strategy to generate biomimetic membrane‐integrated liposomes (MILs) from ACE2‐overexpressing mammalian cells was developed. Using engineered HeLa cells as a model, MILs have been successfully harvested that retained native surface proteins, including ACE2, as confirmed by immunogold TEM and Western blot analysis. These ACE2‐presenting MILs were then coated onto copper nanoparticles (Cu NPs), creating biomimetic Cu@MIL nanostructures with dual functions, including selective viral capture via ACE2‐mediated binding and neutralization, as well as potent antiviral activity from Cu NP disinfection. This synergistic platform effectively camouflages the nanomaterial with host‐mimetic membranes, conferring targeted viral neutralization and disinfection capabilities. Our findings highlight the potential of Cu@MIL nanoparticles as a decoy‐plus antiviral therapeutic for SARS‐CoV‐2, offering a promising strategy to combat COVID‐19 and future pandemics of receptor‐specific pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal and Applied Chemistry, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Department of Oncology, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan.
- Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan.
- Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
- Department of Emergency Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
- School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
ORCID-Profile: Pooja Aich, Oh Seok Kwon, Wei-Peng Li
Förderung
- Kaohsiung Medical University
- National Research Foundation of Korea
- Ministry of Education
- National Science and Technology Council
Zitieren
APA
Aich, P., Chung, W. P., Wang, W. J., Takahashi, H., Hsieh, M. S., Lin, Y. C., Kwon, O. S., Li, W. P., & Huang, W. L. (2026). Biomimetic Copper Nanoparticles Coated with ACE2‐Overexpressing Membranes for Selective SARS‐CoV‐2 Neutralization and Disinfection. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202505424
Vancouver
Aich P, Chung WP, Wang WJ, Takahashi H, Hsieh MS, Lin YC, et al. Biomimetic Copper Nanoparticles Coated with ACE2‐Overexpressing Membranes for Selective SARS‐CoV‐2 Neutralization and Disinfection. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202505424
BibTeX
@article{Aich2026,
author = {Aich, Pooja and Chung, Wei-Pang and Wang, Wen-Jyun and Takahashi, Hidenobu and Hsieh, Ming-Shun and Lin, Ying-Chen and Kwon, Oh Seok and Li, Wei-Peng and Huang, Wei-Lun},
title = {Biomimetic Copper Nanoparticles Coated with ACE2‐Overexpressing Membranes for Selective SARS‐CoV‐2 Neutralization and Disinfection},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202505424}
}
EUVIMED